Advancements in Autoimmune Disease Treatment: From Conventional Therapies to Precision Medicine

Autoimmune diseases encompass a range of disorders where the immune system erroneously attacks the body's own tissues, leading to persistent inflammation and organ damage. Conditions such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and type 1 diabetes arise from a combination of genetic, environmental, and immune system factors. Conventional treatments like corticosteroids and disease-modifying antirheumatic drugs (DMARDs) help control symptoms but do not correct the underlying immune dysfunction, often resulting in adverse effects and long-term complications. Advancements in targeted therapies, immunomodulation, and precision medicine have significantly transformed autoimmune disease management. Monoclonal antibodies and small molecule inhibitors provide more precise immune modulation, enhancing treatment effectiveness while minimizing side effects. Furthermore, emerging therapies, including stem cell treatments, gene editing, and microbiome-based approaches, are opening new possibilities for disease management. The integration of genomic and molecular profiling is also paving the way for personalized medicine, allowing for tailored treatment plans that improve patient outcomes and reduce unnecessary interventions. However, challenges such as disease variability, treatment costs, and accessibility continue to hinder progress. Ongoing research in biologics, gene-based therapies, and artificial intelligence-driven solutions is shaping the future of autoimmune disease treatment. This review highlights recent advancements, emphasizing the shift from generalized immunosuppression to more targeted, personalized, and innovative therapeutic strategies.